P30 CFRTC | Beno Freedman PhD Nephrology | 2022-24 | Modeling CFTR function with human kidney organoids |
CFF RDP | Eric Morrell, MD
Pulmonary | 2021-24 | Role of Soluble PD-L1 in Chronic Lung Allograft Dysfunction |
CFF RDP | Amy Willis, PhD
Biostatistics | 2021-23 | Estimating the composition of the cystic fibrosis pulmonary microbiome
|
P30 CFRTC | Pavan Bhatraju, MD
Pulmonary
| 2018-23 | Identification of Predictive Biomarkers for Antibiotic Associated Nephrotoxicity in Cystic Fibrosis |
P30 CFRTC | Jim Kublin, MD, MPH
Vaccine & ID, Hutch
| 2020-23 | Investigating Mechanisms of Vaccine Response Deficiency in Cystic Fibrosis |
P30 CFRTC | Sakeneh Zraika, PhD
Metabolism | 2020-23 | Impact of Intra-Islet GLP-1 Signaling on ß-cell Function in CFRD |
CFF RDP | Eric Morrell, MD, MA
Pulmonary | 2019-22 | Immune Tolerance and Inflammation in Lung Transplant Rejection |
CFF RDP | David Sherman, PhD
Microbiology | 2019-21 | Inferring drug interactions in M. abscessus using chemo-genomics and orthology |
CFF RDP | Richard James, PhD
Jason Debley, MD
Pediatrics | 2019-20 | Approach to CFTR Editing in Differentiated Airway Epithelial Cells |
P30 CFRTC | Marion Pepper, PhD Immunology | 2018-21 | Pseudomonas-specific immune responses in CF patients |
P30 CFRTC | Jisun Paik, PhD Comparative Medicine
Luke Hoffman, MD, PhD, Pediatrics | 2018-20 | Gastrointestinal dysbiosis as a modifier of CF infant somatic growth: A murine investigation |
P30 CFRTC | Steve Salipante, MD, PhD, Lab Medicine | 2018-20 | Cell-free Bacterial DNA to Identify Mycobacterial Lung Pathogens in CF |
CFF RDP | Andrew Graustein, MD
Pulmonary | 2017-20 | The NLRP3 Inflammasome in The Cystic Fibrosis Lung |
CFF RDP | Thomas Hawn, MD, PhD
Allergy & ID | 2017-19 | The Inflammasome in Cystic Fibrosis |
CFF RDP | Jason Debley, MD
David Nichols, MD
Pediatrics | 2017-19 | Testing association between epithelial chloride transport and measures of clinical improvement |
P30 CFRTC | Matthew Parsek, PhD
Microbiology | 2016-20 | Microbial colonization and adaptation to the CF gut |
P30 CFRTC | Neal Paragas, PhD
Nephrology | 2016-19 | Identification of Biomarkers for Cystic Fibrosis Associated Nephrotoxicity |
P30 CFRTC | Lynn Hajjar, DVM, PhD
Comparative Medicine
| 2016-18 | Lung and gastrointestinal homeostasis in a germ-free CF mouse model |
P30 CFRTC | Marika Bogdani, PhD
Benaroya | 2016-17 | Hyalouronan and hlyaladherins in the pathogenesis of cystic fibrosis related diabetes |
CFF RDP | Steve Salipante, MD, PhD, Lab Medicine | 2015-18 | Mechanisms and fitness of spontaneous aztreonam resistance in Pseudomonas aeruginosa |
CFF RDP | William Altemeier, MD
Pulmonary | 2015-18 | Role of the Microvasculature in Neutrophilic Lung Disease of Cystic Fibrosis |
P30 CFRTC | Steven Kahn, MB, ChB
Metabolism | 2014-19 | Mechanisms of Late Hypoglycemia in Cystic Fibrosis |
P30 CFRTC | Ian de Boer, MD
Nephrology | 2014-18 | Vitamin D metabolism in cystic fibrosis |
CFF RDP | Rafael Hernandez, MD, PhD, Pediatrics | 2014-17 | Efflux Pumps in Nontuberculosis Mycobacteria |
P30 CFRTC | Anne Manicone, MD
Pulmonary | 2014-17 | Functional Consequences and Signaling Pathways of Macrophage Repolarization |
CFF RDP | Donald Chi, DDS, PhD
Dentistry | 2013-17 | Testing a Multifactorial Caries Model for Pediatric Patients with Cystic Fibrosis |
P30 CFRTC | Elhanan Borenstein, PhD, Genome Sciences | 2013-14 | Advanced computational methods for identifying compositional shifts in the CF gut microbiome |
P30 CFRTC | Lucas Hoffman, MD, PhD
Pediatrics | 2013-14 | Acute Effects of Kalydeco in People with CF and the G551D Mutation |
P30 CFRTC | Rebecca Hull, PhD
Metabolism
Srinath Sanda, MD
Pediatrics, UCSF | 2012-17 | Role of Islet Amyloid and IL-1β Signaling in β-cell Loss in Cystic Fibrosis-Related Diabetes |
P30 CFRTC | Ian Sweet, PhD
Metabolism | 2012-15 | Biochemical Mechanisms Mediating Impaired Insulin Secretion in Mouse Models of Cystic Fibrosis |
P30 CFRTC | Lev Becker, PhD
Pediatrics, U Chicago | 2012-15 | Investigating the effects of CFTR Correction on Myeloid Cell Function |
P30 CFRTC | Lev Becker, PhD
Pulmonary | 2010-13 | Macrophage and Dendritic Cell Pathways in Cystic Fibrosis |
P30 CFRTC | Lucas Hoffman, MD, PhD
Pediatrics | 2010-13 | Describing the gut microbiome of early childhood and infant Cystic Fibrosis patients |